Drugs Online |
 |
 | ||
|
Vagifem Vaginal Generic 17 oestradiol |
|
| ||
Drugs Online » Prescription Drugs 16 » Vagifem Vaginal Generic 17 oestradiol IndicationsVagifem is indicated for the treatment of atrophic vaginitis due to oestrogen deficiency.Dosage and AdministrationVagifem is administered deeply into the vagina using the applicator.Initial dose: 1 vaginal tablet a day for two weeksMaintenance dose: 1 vaginal tablet twice a week.Treatment may be started on any convenient day. If a dose is forgotten it should be taken as soon as the patient remembers. A double dose should be avoided.For initiation and continuation of treatment of postmenopausal symptoms the lowest effective dose for the shortest duration should be used (see Warnings and Precautions).Vagifem may be used in women with or without an intact uterus.During treatment especially during the first 2 weeks minimal absorption may be seen but as plasma oestradiol levels after the first 2 weeks usually do not exceed postmenopausal levels the addition of a progestagen is not recommended.AdministrationOpen the blister pack at the plunger end. Insert the applicator in the vagina until resistance is met (8-10 cm). Release the tablet by pressing the plunger. Withdraw the applicator and discard. Buy Vagifem Vaginal Generic 17 oestradiol and other Prescription Drugs 16 products online at Medstore. 3591
About Vagifem Vaginal Generic 17 oestradiol: Product Type: Prescription Drugs 16 Vagifem Vaginal ( Generic 17-oestradiol Estradiol ) Vagifem Vaginal (Generic 17-oestradiol Estradiol) Generic 17-oestradiol Estradiol 25mcg 15 Tablets Generic 17-oestradiol Estradiol Vagifem Vaginal
View more Prescription Drugs 16 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
